@FierceMedDev: Researchers explore 'shape-shifting' material for facial reconstruction. More | Follow @FierceMedDev
@StacyALawrence: ICYMI: Intel, Michael J. Fox Foundation start smartwatch study to track Parkinson's patients. Story | Follow @StacyALawrence
@VarunSaxena2: RT @FierceMedicalDev: We're looking for fierce women at the top of their game in #medtech. Learn more about how to nominate. More | Follow @VarunSaxena2
@EmilyWFierce: Senate Democrats outlining a proposal to crack down on corporate tax inversions. Story via The Wall Street Journal | Follow @EmilyWFierce
> Two TRU-D SmartUVC cleaning robots were sent from the United States to a Liberian hospital to help fight the Ebola outbreak. Read
> Intel and rapper 50 Cent's SMS Audio are teaming up to design fitness-oriented earbuds which will measure heart rate and charge the device while in use. Story
> Bloomberg examines how a newly disclosed device from Accenture and Philips ($PHG) works to control household devices with thought. The device could help ALS and other movement-related disease patients be more independent. More
Biotech News
@FierceBiotech: RT @NickPaulTaylor: EuroBiotech: NeuroSearch convicted of stock manipulation, VBL IPO unravels, Prosensa plans EMA filing and more. Report | Follow @FierceBiotech
@DamianFierce: CF biotech ProQR, pursuing a $75M IPO, employs a "happiness manager." | Follow @DamianFierce
@EmilyMFierce: Glaxo quietly edges toward Ebola vaccine but clinical barriers remain. FierceVaccines story | Follow @EmilyMFierce
> Teva tries laquinimod in Huntington's after repeated MS woes. Story
> CF biotech ProQR shoots for a $75M IPO to challenge Vertex. Article
> Achillion shoulders its way into the hep C race with strong early data. More
Pharma News
@FiercePharma: ICYMI earlier: Skeptical U.K. watchdogs decide to back Gilead's hep C star Sovaldi. News | Follow @FiercePharma
@EricPFierce: Amgen recalls Aranesp from UK, Russia, 7 other countries after polyester particles found in syringes. FiercePharmaManufacturing story | Follow @EricPFierce
@CarlyHFierce: Valeant, Pershing Square: Bring on the SEC insider trading probe. More | Follow @CarlyHFierce
> Roche's Avastin nabs quick FDA nod for cervical cancer use. News
> NICE Zytiga snub is 'plainly illogical,' critics say. Story
> Bloomberg: Roche negotiating for rest of Chugai for $10B. Article